100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Samenvatting 24-25 Hematologie 3 deel 1 : hematologie $5.90
Add to cart

Summary

Samenvatting 24-25 Hematologie 3 deel 1 : hematologie

 1 view  0 purchase
  • Course
  • Institution

Samenvatting vak hematologie deel 1 : hematologie Gegeven in 3de jaar MLT

Preview 4 out of 41  pages

  • December 22, 2024
  • 41
  • 2024/2025
  • Summary
avatar-seller
HEMATOLOGIE 3:
Deel 1 : Hematologie
Lector. Flies Reinoud


Academiejaar
2024 - 2025

,IN HOUD

Herhaling .................................................................................................................................................................. 2

Deel 1 : Afwijkingen van RBC .................................................................................................................................... 3

1. Anemie : inleiding ............................................................................................................................................. 3

2. Afwijkingen van ijzer- en heammetabolisme ................................................................................................... 6

3. Afwijkingen van het DNA-metabolisme ......................................................................................................... 10

4. Hemolytische anemie : Inleiding .................................................................................................................... 10

5. HA : Intracorpusculaire defecten.................................................................................................................... 12

6. HA : Extracorpusculaire defecten ................................................................................................................... 15

7. Hemoglobinopathiën ...................................................................................................................................... 19

8. Thalassemie .................................................................................................................................................... 21

DEEL 2 : Maligne afwijkingen van de WBC ............................................................................................................. 24

1. Inleiding .......................................................................................................................................................... 24

2. Indeling leukemie ........................................................................................................................................... 25

3. Myeloproliferatieve aandoeningen ................................................................................................................ 25

4. Chronische Myeloïde Leukemie ..................................................................................................................... 26

5. Polycythemia vera .......................................................................................................................................... 27

6. Essentiële trombocytemie.............................................................................................................................. 29

7. Myelofibrose (IMF) ......................................................................................................................................... 29

8. Myelodysplastisch syndromen ....................................................................................................................... 30

9. Acute leukemie ............................................................................................................................................... 31

10. Acute Lymfatische Leukemie (ALL) ............................................................................................................... 31

11. Acute Myeloïde Leukemie (AML) ................................................................................................................. 33

12. Lymfoïde Neoplasmata ................................................................................................................................. 34

13. Plasmacelaandoeningen ............................................................................................................................... 38

14. Laboratoriumdiagnostiek Leukemie ............................................................................................................. 40




1
Moons N / Vermeulen A

,HERHALING

REFERENTIEWAARDEN

Man Vrouw Eenheid

RBC 4,3 – 6,0 3,8 – 5,5 Miljoen / µl

HGB 14 – 18 12 – 16 g / dl

HCT 40 – 55 35 – 45 %

MCV 75 – 95 fl

MCH 27 – 32 pg

MCHC 30 – 35 g / dl

RDW < 15 %

WBC 4 000 – 11 000 / µl

TRO 140 000 – 450 000 / µl

RET 0,2 – 2,0 %

Absoluut # RET 60 000 – 100 000 (neonatie 400 000) / µl

RET index 0,4 – 2,22 %


ERYTROPOIESE




2
Moons N / Vermeulen A

, DEE L 1 : AFWIJKIN GEN VAN RBC

Cursus Hematologie : Deel 1: afwijkingen RBC

1. A NE MIE : I NLEIDI NG

1.1 A LGE MEE N
Anemie = bloedarmoede
→ gekenmerkte door daling van Hgb-gehalte

Definitie anemie
• Daling van O2-dragende capaciteit van bloed → komt tot uiting bij verlaagd Hgb-gehalte
• Vermindering van RBC, Hgb en RBC-massa (t.o.v. patiënt zijn basislijn)
22
20
18
Hgb
Hgb-gehalte = parameter voor O2-dragende capaciteit van het bloed 16
14

→ Laag Hgb-gehalte leidt tot weefselhypoxie* 12
10
8
6
Hct = parameter voor bloedvolume en viscositeit 4
2
0




j

m
d




v
2m

3m

4m

6m

1j

j
7




2-6


j
12

-18
s




lw
lw
atu




6-

12



vo
vo
on
*Weefselhypoxie gevolgen




Ne
• Onvoldoende O2-bevoorrading van omliggende weefsels
• Overconsumptie O2 : verhoogde cardiale en pulmonaire activiteit → Tachycardie
• Verhoogde RBC-productie : door stijging EPO (groeifactor)

Klinische symptomen
• Door weefselhypoxie: bleekheid, moe, syncope, vertigo, dyspnoe (kortademigheid)
• Door compensatie: tachycardie, hartruis, verhoogde RBC-productie (botpijn), A.pectoris

Aan- of afwezigheid klinische symptomen hangt af van 4 factoren
1. Snelheid van ontstaan → Snellere geeft ernstigere symptomen
2. Ernst v anemie → milde anemie : zelden symptomen
3. Leeftijd → Jongeren kunnen beter compenseren
4. Zuurstofdissociatiecurve → anemie geeft verhoogde 2,3-DPG productie


Left shift


Right shift




3
Moons N / Vermeulen A

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller nettemoons. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $5.90. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

52510 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$5.90
  • (0)
Add to cart
Added